71308-021 : Olinvyk 2 mg/2ml Intravenous Injection, Solution
NDC: | 71308-021 |
Labeler: | Trevena, Inc. |
Product Type: | Human Prescription Drug |
Drug Name: | Olinvyk |
Dosage Form: | Intravenous Injection, Solution |
Application #: | NDA210730 |
Rev. Date: | |
CSA Schedule: | CII (US) [1] |
[1] Schedule II / IIN Controlled Substance: High potential for abuse which may lead to severe psychological or physical dependence. (i.e. Narcotics such as Dilaudid, Methadone, Demerol, Oxycodone, Percocet, Fentanyl, Morphine, Opium, Codeine, and Hydrocodone ... Schedule IIN stimulants include non-narcotic Amphetamines such as Dexedrine, Adderall, Desoxyn, Methylphenidate (Ritalin) ... Other Schedule II substances include Amobarbital, Glutethimide, and Pentobarbital. More Details: US Dept of Justice Controlled Substance Schedules.
NDC Package Codes:
- 71308-021-10: 10 VIAL, SINGLE‑DOSE IN 1 CARTON (71308‑021‑10) > 2 ML IN 1 VIAL, SINGLE‑DOSE (71308‑021‑01)
Active Ingredients:
- Oliceridine
Dosage Strength:
- 2 mg/2mL
Related Products:
Based on records with the same trade name.- 71308-011 Olinvyk 1 mg/ml Intravenous Injection, Solution by Trevena, Inc.
- 71308-301 Olinvyk 30 mg/30ml Intravenous Injection, Solution by Trevena, Inc.
NDC QR Code
Scan the QR code below to easily reference this data in the future:< Prev: 71308-011Next: 71308-301 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.